DK1527092T3 - GPI-forankret glykoprotein ACA som en ny tumormarkör - Google Patents

GPI-forankret glykoprotein ACA som en ny tumormarkör

Info

Publication number
DK1527092T3
DK1527092T3 DK03784192T DK03784192T DK1527092T3 DK 1527092 T3 DK1527092 T3 DK 1527092T3 DK 03784192 T DK03784192 T DK 03784192T DK 03784192 T DK03784192 T DK 03784192T DK 1527092 T3 DK1527092 T3 DK 1527092T3
Authority
DK
Denmark
Prior art keywords
aca
gpi
relates
anchor
tumor marker
Prior art date
Application number
DK03784192T
Other languages
Danish (da)
English (en)
Inventor
Zorica Becker-Kojic
Peter Terness
Original Assignee
Becker Kojic Zorica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becker Kojic Zorica filed Critical Becker Kojic Zorica
Application granted granted Critical
Publication of DK1527092T3 publication Critical patent/DK1527092T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK03784192T 2002-08-06 2003-08-06 GPI-forankret glykoprotein ACA som en ny tumormarkör DK1527092T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02017524A EP1391463A1 (de) 2002-08-06 2002-08-06 GPI verankertes Glykoprotein ACA als neuer Tumormarker
PCT/EP2003/008711 WO2004014948A2 (en) 2002-08-06 2003-08-06 Gpi anchored glycoprotein aca as a novel tumor marker

Publications (1)

Publication Number Publication Date
DK1527092T3 true DK1527092T3 (da) 2008-11-10

Family

ID=30775786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03784192T DK1527092T3 (da) 2002-08-06 2003-08-06 GPI-forankret glykoprotein ACA som en ny tumormarkör

Country Status (9)

Country Link
US (1) US20060276375A1 (de)
EP (2) EP1391463A1 (de)
JP (2) JP2006516087A (de)
AT (1) ATE400585T1 (de)
AU (1) AU2003250217A1 (de)
DE (1) DE60322065D1 (de)
DK (1) DK1527092T3 (de)
ES (1) ES2322349T3 (de)
WO (1) WO2004014948A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2386311T3 (es) * 2004-05-05 2012-08-17 Zorica Becker-Kojic Uso de anticuerpos anti glicoproteína ACA para obtener/mantener células madre pluripotentes no embrionarias
EP2749640A1 (de) 2012-12-27 2014-07-02 Zorica Becker-Kojic Verfahren zur Herstellung ektodermaler, mesodermaler und endodermaler Zellen sowie pluripotenter Stammzellen, hämatopoetischer Stammzellen, Seitenpopulationszellen und mesenchymalen Stammzellen sowie ein Verfahren zur Entdifferenzierung peripherer Blutzellen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5519120A (en) * 1989-04-07 1996-05-21 Cancerforskningsfondet Af 1989 Urokinase-type plasminogen activator receptor antibodies

Also Published As

Publication number Publication date
ATE400585T1 (de) 2008-07-15
WO2004014948A3 (en) 2004-04-15
JP2006516087A (ja) 2006-06-22
JP2010154859A (ja) 2010-07-15
JP5486945B2 (ja) 2014-05-07
US20060276375A1 (en) 2006-12-07
ES2322349T3 (es) 2009-06-19
DE60322065D1 (de) 2008-08-21
AU2003250217A1 (en) 2004-02-25
WO2004014948A2 (en) 2004-02-19
EP1527092A2 (de) 2005-05-04
EP1391463A1 (de) 2004-02-25
EP1527092B1 (de) 2008-07-09

Similar Documents

Publication Publication Date Title
MA29649B1 (fr) Nouveaux derives de 2,4- dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
DK1628685T3 (da) Antivirale phosphonatanaloge
GT199800113A (es) Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
DE3482589D1 (de) Retro-inverse analoga des bradykinin-potentialisierenden peptids bpp-5a und verfahren zu ihrer herstellung.
BR0210344A (pt) Inibidores da hiv protease, composições contendo os mesmos, seus usos farmacêuticos e materiais para a sua sìntese
ECSP055621A (es) Aza-biciclo-alquil-éteres y su uso como agonistas de alfa7-nachr
HUP0003332A2 (hu) Triazolszármazékok és dopamin-D3-ligandumként való alkalmazásuk
CY1114679T1 (el) Συνθεσεις για διαγνωση και θεραπεια ασθενειων που συνδυαζονται με παρεκκλινουσα εκφραση φουτρινων (r-σπονδινων)
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
SE0301373D0 (sv) Novel compounds
DE60139768D1 (de) Gennachweisverfahren zur verbesserung der wahrscheinlichkeit einer wirkungsvollen antwort auf eine k
GT200200100AA (es) Resolucion de sal quiral(solicitud fraccionaria no.1 derivada de la patente pi-2002-0100).
CA2313638A1 (en) Cyclohexene carboxylates as neuraminidase inhibitors
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
CY1110185T1 (el) Τροποποιημενη πρωτεϊνη vp1-καψιδιου του παρβοϊου β19
GT200500383A (es) Sulfonamido-macrociclos y sus sales, una composicion farmaceutica que comprende estos compuestos, un metodo de preparacion y el uso de los mismos
DE60034316D1 (de) Verfahren zur herstellung von (2r)-2-propyloktansäure
BRPI0511639A (pt) pirrolidin-2-onas substituìdas
NO20054631L (no) Antistoff mot tumorspesifikt antigen som mal
EA200500095A1 (ru) Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств
DK1527092T3 (da) GPI-forankret glykoprotein ACA som en ny tumormarkör
ATE320420T1 (de) Verfahren zur herstellung von optisch aktiven naphthalinderivaten und darin eingesetzte optische resolver
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
DK1142905T3 (da) Hidtil ukendt depsipeptidforbindelse
JP7244511B2 (ja) Ｌｙ６Ｋを阻害する化合物およびそれらを使用する方法